APA način citiranja

Fala, L. (2016). Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Heart Failure. Am Health Drug Benefits.

Čikaški stil citiranja

Fala, Loretta. "Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Heart Failure." Am Health Drug Benefits 2016.

MLA način citiranja

Fala, Loretta. "Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Heart Failure." Am Health Drug Benefits 2016.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.